From January 1, 2024 to March 31, 2024, the company has repurchased 62,607 shares, representing 2.15% for $0.1 million. With this, the company has completed the repurchase of 315,462 shares, representing 10.37% for $0.57 million under the buyback announced on January 31, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.68 USD | -4.55% | -9.19% | +16.67% |
23/04 | Silo Pharma, Inc. Announces Positive Results for Intranasal PTSD Treatment | CI |
10/04 | Silo Pharma Says It Exercised Option to License Alzheimer's Therapeutic From Columbia University | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.67% | 4.78M | |
-2.61% | 89.08B | |
+3.55% | 40.9B | |
-14.40% | 32.25B | |
+55.89% | 25.14B | |
-15.96% | 15.39B | |
-15.50% | 11.91B | |
-41.29% | 11.89B | |
-11.75% | 11.64B | |
+7.87% | 9.03B |
- Stock Market
- Equities
- SILO Stock
- News Silo Pharma, Inc.
- Tranche Update on Silo Pharma, Inc.'s Equity Buyback Plan announced on January 31, 2023.